Hartzen S H, Frimodt-Møller N, Thomsen V F
Department of Antibiotics, Statens Seruminstitut, Copenhagen, Denmark.
APMIS. 1994 Mar;102(3):219-26.
The in vitro activity of deferoxamine (DFO) both per se and in combination with the reductant ascorbic acid (AA) was determined against 10 E. coli strains, 5 P. mirabilis strains, and 10 coagulase-negative staphylococci. In terms of interaction, the influence of DFO on the activities of cephalothin and gentamicin was furthermore investigated against the same panel of strains employing a macrobroth dilution technique and killing-curve kinetics. The MICs of cephalothin and gentamicin were lowered for one half of the strains. Moreover, DFO prolonged the generation times of logarithmic growth phase considerably, especially when the reductant AA was present. The interactions between DFO or DFO+AA and subinhibitory concentrations of antibiotics were established by the application of growth constants, and resulted in synergy for 15 out of 25 strains with cephalothin and 9 out of 25 strains with gentamicin.
测定了去铁胺(DFO)本身及其与还原剂抗坏血酸(AA)联合使用时对10株大肠杆菌、5株奇异变形杆菌和10株凝固酶阴性葡萄球菌的体外活性。在相互作用方面,还采用宏观肉汤稀释技术和杀菌曲线动力学,针对同一组菌株研究了DFO对头孢噻吩和庆大霉素活性的影响。头孢噻吩和庆大霉素的最低抑菌浓度(MIC)在一半的菌株中降低。此外,DFO显著延长了对数生长期的代时,尤其是在存在还原剂AA的情况下。通过应用生长常数确定了DFO或DFO + AA与亚抑菌浓度抗生素之间的相互作用,结果显示,与头孢噻吩联合时,25株中有15株产生协同作用;与庆大霉素联合时,25株中有9株产生协同作用。